Skip to main content

MARSHALL WACE, LLP

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in CTMX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,341,315
-$8,108,111 QoQ
Shares Held
3,024,351
-26.9% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 178 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. CTMX ranks #64 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTMX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,341,315 3,024,351
2026-03-31 $19,449,426 4,138,176
2025-12-31 $4,928,547 1,156,936
2025-09-30 $3,524,926 1,104,993
2025-06-30 $5,341,586 2,353,122
2025-03-31 $54,402 85,539
2024-03-31 $113,990 52,289
2023-12-31 $563,077 363,276
2023-09-30 $487,094 377,593
2023-06-30 $1,160,141 674,501
2023-03-31 $1,102,206 729,938
2022-09-30 $58,030 40,021
2022-06-30 $117,383 64,144
2022-03-31 $40,760 15,266
2020-03-31 $900,404 117,393